Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Erik Kraenzler, MD, is the Operating Room Director in the Department of Thoracic and Cardiovascular Surgery and Cardiothoracic Anesthesia. He is board-certified in anesthesiology, critical care medicine and perioperative transesophageal echocardiography. He specializes in cardiothoracic anesthesiology, intraoperative echocardiography and resident education. He was also recently appointed as the Assistant Medical Director for Clinical Supply Chair Management.
Following undergraduate work at the University of Wisconsin in his home state, Dr. Kraenzler received his medical degree from the Medical College of Wisconsin in Milwaukee, where he completed his internship in general surgery. He took his residency in anesthesiology at the Loyola University Medical Center in Illinois prior to receiving fellowships in cardiothoracic anesthesia and advanced echocardiography from Cleveland Clinic.
He was appointed to the Cleveland Clinic in 1988 as a staff anesthesiologist in the Department of Cardiothoracic Anesthesia. He was the Head of the Section of General Thoracic Anesthesiology in the Department of Cardiothoracic Anesthesia, Anesthesiology Institute; the Assistant Director of Residency Education in the Anesthesiology Institute; Director of the Fellowship Program in the Department of Cardiothoracic Anesthesia; and a Staff Anesthesiologist in the Department of Cardiothoracic Anesthesia, Anesthesiology Institute at the Cleveland Clinic.
Dr. Kraenzler’s contributions to cardiothoracic anesthesia include a patent of a Bronchial Blocker Endotracheal Apparatus for one lung ventilation and clinical research that has focused on interventions during cardiopulmonary bypass, lung ventilation, and coronary artery surgery. He has been invited to lecture on his specialty interests at medical symposia and conferences in Hungary and Canada, in addition to invitations to lecture locally and nationally.
He has published articles and abstracts on his specialty interests, clinical experience and research in leading medical journals including Anesthesiology, Journal of Cardiothoracic Anesthesiology, and Journal of Clinical Monitoring. In addition, he is co-author of a two book chapters related to cardiothoracic anesthesia in medical textbooks on anesthesia and thoracoscopic surgery.
Dr. Kraenzler is a member of the American Society of Anesthesiologists, the American Society of Echocardiography, the International Anesthesia Research Society, the Society of Cardiovascular Anesthesiologists, the Society for Education in Anesthesia and the Ohio State Medical Association.
3D echocardiography, assessment and treatment for ventricular dysfunction, cardiac rapid response (CMET) and cardiopulmonary resuscitation, cardiothoracic anesthesia, cardiothoracic anesthesiology, cardiovascular critical care, critical care medicine, fellow and resident education, heparin-induced thrombocytopenia, intraoperative echocardiography, intraoperative TEE, intraoperative transesophageal echocardiography, neurologic protection during aortic surgery, pain management for cardiac patients, perioperative echocardiography, quality assessment and improvement, quality assurance, quality of service, resident teaching, risk stratification, surgery outcomes research, transcutaneous devices in cardiovascular disease, valvular heart disease
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/8/2013, Dr. Kraenzler has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.